On May 30, the Central Epidemic Command Center (CECC) stated that domestic manufacturing of vaccine is an established national policy for fighting against COVID-19 as the disease is likely to become like flu in the future; therefore, the government must secure COVID-19 vaccines as strategic supplies. Taiwan adopts the approach of pre-purchasing to secure the vaccine doses it has bought at this stage, including 20 million doses from overseas and 10 million doses of domestically manufactured vaccines.


The CECC pointed out that Taiwan had pre-purchased vaccine doses from AstraZeneca and Moderna before they completed their phase 2 or 3 clinical trials.